Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $736.08M.
ENTERPRISE VALUE (EV)
$736.08M
Design Therapeutics, Inc.
Market Cap
$752.29M
Enterprise Value (EV)
$736.08M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Design Therapeutics, Inc. (DSGN) | $752.29M | $736.08M |
| Mesa Laboratories, Inc. (MLAB)vs › | $763.75M | $834.41M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.84M | $736.34M |
| Faeth Therapeutics, Inc. (FTH)vs › | $738.30M | $711.99M |
| Candel Therapeutics, Inc. (CADL)vs › | $736.18M | $584.13M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | $791.26M |
| Achieve Life Sciences, Inc. (ACHV)vs › | $730.28M | $697.27M |
| ArriVent BioPharma, Inc. (AVBP)vs › | $727.50M | $573.17M |
| Sana Biotechnology, Inc. (SANA)vs › | $777.94M | $794.60M |
| Apnimed, Inc. (APMD)vs › | $781.33M | N/A |
Market Cap
$752.29M
Total Debt
$645000.00
Cash
$16.86M
Enterprise Value
$736.08M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
